<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 28.3</label>
 <caption>
  <p>The molecular techniques for target selections</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Technology</th>
    <th>Use</th>
    <th>Advantages</th>
    <th>Disadvantages</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Signature-tagged mutagenesis</td>
    <td>Identification of genes required for pathogen survival in animal model</td>
    <td>Identifies essential genes in vivo</td>
    <td>Limited to genes that are not required in vitro, library construction</td>
   </tr>
   <tr>
    <td>In vivo expression technology</td>
    <td>Identification of pathogen induced in vivo</td>
    <td>Identifies genes induced in vivo</td>
    <td>Increased expression does not necessarily mean the gene is essential in vivo, further validation required, construct initial library</td>
   </tr>
   <tr>
    <td>Microarrays</td>
    <td>Understanding host response to pathogens, correlating gene expression with pathogenicity, identifying molecular targets of antimicrobial compounds, inferring function of unknown genes</td>
    <td>Low resource, no library construction required, looks at all genes simultaneously</td>
    <td>Increased expression does not necessarily mean the gene is essential, further validation required, technically difficult to use for pathogens grown in vivo</td>
   </tr>
   <tr>
    <td>Comparative genomics</td>
    <td>Identification of pathogenicity-related genes, identification of antigens for vaccine development, selecting targets conserved across multiple pathogens, selecting targets with lowest homology to human proteins</td>
    <td>No experimental work required, total in silico work</td>
    <td>Spectrum and selectivity analysis based on linear sequencing, analysis could be misleading</td>
   </tr>
   <tr>
    <td>Structural genomics</td>
    <td>Select conserved target across multiple pathogen, selecting targets with lowest homology to human protein</td>
    <td>Spectrum and selectivity analysis based on 3D analysis of the active site</td>
    <td>High resource required to solve the crystal structure</td>
   </tr>
   <tr>
    <td>Next-gen sequencing</td>
    <td>Whole genome sequencing, investigation of genome diversity, metagenomics, epigenetics, discovery of uncoding RNAs, protein-binding sites</td>
    <td>Higher sensitivity and the potential to detect the full spectrum of virus including unknown and unexpected viruses</td>
    <td>Sequencing in bulk is error-prone</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
